Royal Sense
110.00
-5.00(-4.35%)
Market Cap₹58.83 Cr
PE Ratio8.60
IndustryHealthcare
Company Performance:
1D-4.35%
1M+1.85%
6M-32.14%
1Y-48.71%
5Y-10.38%
View Company Insightsright
More news about Royal Sense
08Apr 26
Royal Sense Limited Responds to BSE Clarification on Stock Price Movement
Royal Sense Limited responded to BSE's inquiry about recent stock price movements on April 8, 2026. The company attributed the price changes to market-driven conditions and speculation while confirming full compliance with SEBI disclosure regulations. Royal Sense reiterated its commitment to timely disclosure of material information affecting its securities.
 no imag found
28Feb 26
Royal Sense Limited Announces Resignation of Company Secretary & Compliance Officer
Royal Sense Limited has announced the resignation of Company Secretary & Compliance Officer Ms. Ragini Maurya, effective February 28, 2026. Ms. Maurya, holding ICSI Membership No. ACS:73697, cited personal reasons for her departure. The company management accepted her resignation and relieved her from all duties with immediate effect. The resignation was communicated to BSE in full compliance with SEBI (LODR) Regulations, 2015, with all required documentation provided.
 no imag found
24Feb 26
Royal Sense Limited Launches First Stergic Pharmacy Counter in Delhi
Royal Sense Limited successfully launched its first Stergic Pharmacy counter in Delhi on February 23, 2026, through its wholly owned subsidiary Stergic Retail Private Limited. The pharmacy is located at Deep Vihar, Rohini Sector-22, Delhi, and represents what the company describes as a significant growth opportunity. The company has committed to providing regular updates on future developments to exchanges and stakeholders.
 no imag found
28Jan 26
Royal Sense Limited Opens New Warehouse Facility in Sonipat on Five-Year Lease
Royal Sense Limited has opened a new warehouse facility at Village Nathupur, Sonipat on a five-year lease agreement from February 1, 2026 to January 31, 2031. The company made this disclosure in compliance with SEBI (LODR) Regulations, 2015, demonstrating its commitment to regulatory transparency and operational expansion through strategic infrastructure investments.
 no imag found
17Dec 25
Royal Sense Limited Completes Allotment of 3.92 Lakh Convertible Warrants Worth ₹98.39 Crores
Royal Sense Limited has successfully completed the allotment of 3,92,000 convertible warrants worth ₹98.39 crores following board approval on December 17, 2025. The warrants were issued at ₹251 per warrant to 22 allottees, with the largest allocation going to Jyoti Asija (19,000 warrants), and warrant holders have 18 months to convert into equity shares.
 no imag found
16Dec 25
Royal Sense Limited Secures Major Tender Worth Up to ₹100 Crores from Central Procurement Agency
TTG Innovations Private Limited, set to merge with Royal Sense Limited, has been awarded a significant tender by the Central Procurement Agency under the Directorate General of Health Services. The two-year contract involves supplying comprehensive surgical sutures, potentially increasing sales by up to ₹100 crores. The tender covers various suture types including absorbable, non-absorbable, monofilament, braided, and specialty sutures. This development comes amid ongoing corporate restructuring, with Royal Sense having received a No Objection Certificate from BSE Limited for the proposed merger.
 no imag found
20Nov 25
Royal Sense Limited Receives BSE No-Adverse Observation Letter for Merger with TTG Innovations
Royal Sense Limited (RSL) has received a no-adverse observation letter from BSE Limited for its proposed merger with TTG Innovations Private Limited (TIPL). The letter, issued on November 19, 2025, is valid for six months and allows RSL to file the merger scheme with NCLT, subject to compliance with 15 specific conditions. The merger, approved by RSL's Board on May 26, 2025, involves the absorption of TIPL into RSL under sections 230 to 232 of the Companies Act, 2013. This development marks a significant step forward in the merger process, positioning RSL to proceed with NCLT filing.
 no imag found
12Aug 25
Royal Sense Limited Unveils 'Stergic Pharmacy' Franchise Model, Targets Nationwide Expansion
Royal Sense Limited announced the launch of its new franchise business model, 'Stergic Pharmacy', on August 12, 2025. The initiative aims to establish a network of franchise-owned and company-operated (FOCO) retail stores across India, offering over 500 products. The company has received more than 125 franchise applications and is currently evaluating them. Managing Director Rishabh Arora signed the regulatory filing, emphasizing the importance of this growth strategy in the pharmaceutical retail sector.
 no imag found
Royal Sense
110.00
-5.00
(-4.35%)
1 Year Returns:-48.71%
Industry Peers
Poly Medicure
1,664.40
(+0.78%)
Tarsons Products
308.75
(-2.26%)
Q-Line Biotech
539.00
(-0.82%)
Laxmi Dental
221.22
(-0.32%)
Osel Devices
443.00
(-1.12%)
Fabtech Technologies
158.10
(-0.11%)
Vasa Denticity
376.00
(+1.25%)
Prevest Denpro
383.65
(-1.60%)
Aprameya Engineering
151.05
(+3.35%)